Skip to main content
Independent science journalism
We do not sell or supply peptides
Peptide
Science
Daily
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Search
⌘K
Subscribe
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Theme
Subscribe to the newsletter
We do not sell or supply peptides.
Home
Trials
NCT06629688
Clinical Trials · NCT06629688
Semaglutide and Intestinal Iron Absorption
Completed
N/A
Semaglutide
(Approved)
Phase
N/A
Recruitment status
Completed
Sponsor
University Hospital Dubrava
Enrollment
51
Start date
Nov 2023
Locations
1 site, Croatia
Primary endpoint
General objective
View Semaglutide compound reference